Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Wilex receives preliminary results of phase III Redectane trial

Dec. 3, 2009

FDA clears ProParaflu+ parainfluenza assay for marketing

Dec. 2, 2009

FDA approves Avioq HIV-1 microelisa system for detection of antibodies against HIV-1

Dec. 2, 2009

Clarient is granted exclusive right to commercialize MUC1* diagnostic cancer test

Dec. 2, 2009

Photocure's NDA for Hexvix to be reviewed by FDA in December 2009

Nov. 30, 2009

HairDX launches HairDX (RxR) genetic test to assess risk for BPH and response to finasteride

Nov. 23, 2009

Clinical Data starts phase III Stedivaze trial for cardiac stress testing

Nov. 20, 2009

FDA grants EUA to Roche's RealTime Ready Influenza A/H1N1 Detection Set

Nov. 18, 2009

Pikamab to customize cancer antibody therapies with ADCC Therasight

Nov. 16, 2009

PulmoBind has potential to diagnose conditions affecting pulmonary circulation

Nov. 16, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...